ARNA - Arena Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 52.79B
Enterprise Value 31.73B
Trailing P/E 4.50
Forward P/E 1-11.07
PEG Ratio (5 yr expected) 1-0.32
Price/Sales (ttm)3.41
Price/Book (mrq)2.24
Enterprise Value/Revenue 32.12
Enterprise Value/EBITDA 62.75

Trading Information

Stock Price History

Beta (3Y Monthly) 1.11
52-Week Change 332.38%
S&P500 52-Week Change 37.40%
52 Week High 359.13
52 Week Low 331.97
50-Day Moving Average 354.92
200-Day Moving Average 347.62

Share Statistics

Avg Vol (3 month) 3537.2k
Avg Vol (10 day) 3531.59k
Shares Outstanding 549.57M
Float 46.25M
% Held by Insiders 10.16%
% Held by Institutions 185.23%
Shares Short (Jun 14, 2019) 43.65M
Short Ratio (Jun 14, 2019) 46.06
Short % of Float (Jun 14, 2019) 47.37%
Short % of Shares Outstanding (Jun 14, 2019) 47.36%
Shares Short (prior month May 15, 2019) 43.73M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jun 19, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 76.19%
Operating Margin (ttm)76.51%

Management Effectiveness

Return on Assets (ttm)38.78%
Return on Equity (ttm)68.14%

Income Statement

Revenue (ttm)817.27M
Revenue Per Share (ttm)16.54
Quarterly Revenue Growth (yoy)45,544.30%
Gross Profit (ttm)-97.06M
EBITDA 628.84M
Net Income Avi to Common (ttm)622.7M
Diluted EPS (ttm)12.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.1B
Total Cash Per Share (mrq)22.28
Total Debt (mrq)58.15M
Total Debt/Equity (mrq)4.68
Current Ratio (mrq)35.51
Book Value Per Share (mrq)25.09

Cash Flow Statement

Operating Cash Flow (ttm)635.22M
Levered Free Cash Flow (ttm)406.34M